Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · IEX Real-Time Price · USD
0.649
+0.051 (8.61%)
At close: May 31, 2024, 4:00 PM
0.653
+0.003 (0.48%)
After-hours: May 31, 2024, 7:53 PM EDT
Cara Therapeutics Stock Forecast
CARA's stock price has decreased by -79.58% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Cara Therapeutics stock have an average target of 10.93, with a low estimate of 1.00 and a high estimate of 28. The average target predicts an increase of 1,583.09% from the current stock price of 0.65.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CARA stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 1 | 1 | 1 | 1 | 1 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 7 | 7 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +669.94% | May 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3.6 | Strong Buy | Reiterates | $3.6 | +454.36% | May 15, 2024 |
Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +669.94% | May 14, 2024 |
Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +669.94% | Apr 10, 2024 |
Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +669.94% | Mar 28, 2024 |
Financial Forecast
Revenue This Year
6.54M
from 20.97M
Decreased by -68.80%
Revenue Next Year
6.93M
from 6.54M
Increased by 5.93%
EPS This Year
-1.27
from -2.19
EPS Next Year
-0.90
from -1.27
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 10.4M | 13.2M | 17.4M | 45.8M | 80.6M |
Avg | 6.5M | 6.9M | 7.2M | 16.8M | 71.1M |
Low | 4.7M | 3.1M | 1.5M | 5.8M | 57.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -50.2% | 101.5% | 150.9% | 539.3% | 379.3% |
Avg | -68.8% | 5.9% | 3.3% | 134.7% | 322.6% |
Low | -77.6% | -53.2% | -78.8% | -19.3% | 239.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.02 | -0.71 | -0.48 | -0.33 | -0.03 |
Avg | -1.27 | -0.90 | -0.80 | -0.69 | -0.35 |
Low | -1.35 | -1.11 | -1.20 | -1.01 | -0.56 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.